BioSpace News Archive

Business

Premia Spine Appoints Three New Board Advisors

Premia Spine today announced the appointment of three new advisors to its board of directors.

December 8, 2021
·
7 min read
FDA

FoundationOne®CDx Receives FDA Approval as a Companion Diagnostic for BRAF Inhibitor Therapeutics in Melanoma

Foundation Medicine, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®CDx.

December 8, 2021
·
4 min read
Drug Development

PureTech Presents Preclinical Proof-of-Concept Data for LYT-300 (Oral Allopregnanolone) as Potential Treatment for Neurological and Neuropsychological Conditions

PureTech Health plc today announced the presentation of preclinical proof-of-concept data at the 60th American College of Neuropsychopharmacology (ACNP) Annual Meeting.

December 8, 2021
·
9 min read
Business

Rocket Pharmaceuticals Appoints Martin L. Wilson as General Counsel and Chief Compliance Officer

Rocket Pharmaceuticals, Inc. today announces the appointment of Martin L. Wilson as General Counsel, Chief Compliance Officer and Senior Vice President.

December 8, 2021
·
6 min read
Drug Development

Takeda Announces Publication of Data from SOLSTICE, a Pivotal Phase 3 Trial for LIVTENCITY™ (Maribavir) in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance)

Takeda Pharmaceutical Company today announced that the data from the pivotal Phase 3 SOLSTICE clinical trial of LIVTENCITY were published in the journal of Clinical Infectious Diseases (CID).

December 8, 2021
·
16 min read
BioNTech to Hold Digital Press Conference to Provide an Update on Omicron Variant

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will hold a digital press conference on Wednesday, December 8, 2021, to present the results from initial laboratory studies which started about two weeks ago.

December 8, 2021
·
1 min read
Biotech Bay

Avistone Pharmaceuticals Secures $200 Million Strategic Investment from Vivo Capital, Bain Capital and Primavera Capital

Avistone Pharmaceuticals today announced it has received a strategic investment of more than $200 million led by Vivo Capital with participation from Bain Capital and Primavera Capital (collectively the “Investor Group”).

December 8, 2021
·
7 min read
Biotech Beach

GT Biopharma Demonstrates Novel B7-H3 Targeting Dual Camelid Nanobody BiKE and GTB-5550 Induce NK Cell Activation Against Broad Spectrum of Tumors at ESMO IO Congress 2021

GT Biopharma, Inc. today announced that the Company’s mini-poster presentation abstract is now broadly available on the European Society for Medical Oncology (“ESMO”) Immuno-Oncology (“IO”) Congress 2021 abstracts webpage.

December 8, 2021
·
9 min read
BioCapital

KeifeRx Completes $6 Million Series A Financing and Enhances Board of Directors

Financing and Board appointments provide foundation for KeifeRx to accelerate development of its pipeline of optimized tyrosine kinase inhibitors targeting neurodegenerative diseases.

December 8, 2021
·
6 min read
Business

Medable and Vault Health Partner to Expand Direct-to-Patient Testing and eCare for Decentralized Clinical Trials

Medable and Vault Health Partner to Expand Direct-to-Patient Testing and eCare for Decentralized Clinical Trials.

December 8, 2021
·
4 min read